You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 302 No. 15, October 21, 2009 TABLE OF CONTENTS
  JAMA
  •  Online Features
  JAMA Patient Page
 This Article
 •Full text
 •PDF
 •Spanish PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in JAMA
 Topic Collections
 •Cardiovascular System
 •JAMA Patient Page
 •Cardiovascular Disease/ Myocardial Infarction
 •Congestive Heart Failure/ Cardiomyopathy
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Hypertrophic Cardiomyopathy

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Cardiomyopathies are diseases affecting heart muscle. In hypertrophic cardiomyopathy (HCM, aka idiopathic hypertrophic subaortic stenosis, asymmetric septal hypertrophy, hypertrophic obstructive cardiomyopathy) sarcomeres (units of heart muscle) enlarge, causing heart muscle cells to hypertrophy (increase in size). This causes the heart muscle to thicken unevenly and changes the way different parts of the heart move, which then requires it to work harder to pump blood. In HCM, hypertrophy usually involves the septum (wall) between the ventricles (lower heart chambers), which differs from other types of cardiomyopathy. As part of the hypertrophy process, the normal pattern of muscle cells is upset and can lead to problems with electrical function of the heart, resulting in arrhythmias (abnormal heartbeat). The first case of HCM was diagnosed 50 years ago. It has since been found to affect 0.2% to 0.5% of the general population and appears in all racial groups. It is the most common . . . [Full Text of this Article]

CAUSE

Huan J. Chang, MD, MPH, Writer; Cassio Lynm, MA, Illustrator; Richard M. Glass, MD, Editor



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED ARTICLE

Implications of Hypertrophic Cardiomyopathy Transmitted by Sperm Donation
Barry J. Maron, John R. Lesser, Nelson B. Schiller, Kevin M. Harris, Colleen Brown, and Heidi L. Rehm
JAMA. 2009;302(15):1681-1684.
ABSTRACT | FULL TEXT  






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2009 American Medical Association. All Rights Reserved.